Cardiac- Oncology
Cardio-oncology is another term to describe the efforts to prevent or treat patients with a tumor who are facing heart issues caused by cancer medicines. Although numerous malignancy patients also have conditions associated with Chronic obstructive pulmonary disease (COPD), other infections or chronic kidney disease (CKD), the descent of heart disease in these patients has led to the development of this new field. Cardio-oncology includes malignancy specialists (oncologists), cardiologists and analysts.
Cardio-oncology is a rapidly growing discipline aiming at reducing the effects of cardiovascular illnesses and mortality in cancer survivors. To achieve this goal, patients are screened and profiled, and their cardio toxicity risk is monitored and analyzed before and after chemotherapy to look for early signs or indications of heart disease. Transthoracic echocardiography in cardiovascular imaging, in particular, plays a critical role in the standard evaluation and serial follow-up of cardio-oncology patients. The mechanism of cardio toxicity of popular chemotherapeutics is linked to an increased risk of left ventricular systolic dysfunction in cardio-oncology patients.